Overview

Study To Evaluate the Safety of Bivalent Vaccine

Status:
Completed

Trial end date:
2006-12-01

Target enrollment:

Participant gender:

Summary

To assess the safety of a bivalent vaccine of two new influenza virus reassortants in healthy adults prior to the release of the trivalent vaccine (FluMist) containing them.

Phase:

Phase 3

Details

Lead Sponsor:

MedImmune LLC